Title of the centre:
WHO Collaborating Centre for International Drug Monitoring
Director / Head:
Professor Marie Lindquist
Institution:
The Uppsala Monitoring Centre
Address:
Box 1051
S-751 40
Town:
Uppsala
Country:
SWEDEN
Region:
EURO
Phone:
(46-18) 65 60 60
Fax:
(46-18) 65 60 88
Date of Designation:
20/Jan/1977
Last Redesignation:
23/Jul/2013
Expiry:
23/Jul/2017
Date of Discontinuation:
Terms of Reference:
- Lead scientific development in the WHO Medicines Safety Programme particularly regarding:
• Identification and explanation of important safety signals related to medicinal products
• Develop best practices in pharmacovigilance
• Improve the visibility and status of pharmacovigilance globally
- Provide useful, high-quality and cost-effective pharmacovigilance products and services to member countries of the WHO Medicines Safety Programme for local applicability building on international standards
- Contribute to capacity building in WHO member countries in establishing and supporting sustainable, high quality pharmacovigilance systems and evaluating their performance.
-
-
-
-
-
-
-
Subjects:
- Pharmaceuticals (including essential drugs and medicines)
-
-
Types of activity:
- Collection; collation and dissemination of information
-
-
WHO organization wide expected result:
| |
11.2 - International norms, standards and guidelines for the quality, safety, efficacy and cost effective use of medical products and technologies developed and their national and/or regional implementation advocated and supported. |
| |
|
| |
|
Responsible Officer:
RAGO Lembit
Phone:
14420/12657
Technical Counterpart:
PEDERSEN Hanne Bak
Phone:
+45 39171432
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork
|